YU21391A - Triciklični-ciklični amini kao novi inhibitori holinesteraze - Google Patents

Triciklični-ciklični amini kao novi inhibitori holinesteraze

Info

Publication number
YU21391A
YU21391A YU21391A YU21391A YU21391A YU 21391 A YU21391 A YU 21391A YU 21391 A YU21391 A YU 21391A YU 21391 A YU21391 A YU 21391A YU 21391 A YU21391 A YU 21391A
Authority
YU
Yugoslavia
Prior art keywords
cholinesterase inhibitors
tricyclic
hydrogen
ring
cyclic amines
Prior art date
Application number
YU21391A
Other languages
English (en)
Inventor
Y.L. Chen
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU21391A publication Critical patent/YU21391A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Abstract

TRICIKLIČNI-CIKLIČNI AMINI KAO NOVI INHIBITORI HOLINESTERAZE, opisana su jedinjenja formule (I) u kojoj E je ugljenik ili azot, G je azot, prstena je benzo, pirido ili tieno, dva od R3, R4, R5 i R6 su vodonik, a druga dva su nezavisno odabrani iz grupe koju sačinjavaju vodonik, metil, etil, propil, metoksi, etoksi, propiloksi, benziloksi, hidroksi, toziloksi, fluoro, acetoksi, N-etilkarbamatni ester i N-metilkarbamatni estar; X je kiseonik ili sumpor i vezano je za ugljenik u položaju "I" prstena D, svako od R2, R11, R12 i R13 je vodonik, ugljovodonični niz za koje P je vezano je prosta ili dvoguba veza vezana za prsten D, i P je: jedinjenja formule I su inhibitori holinestereze i koriste se za povećanje pamćenja kod pacijenta koji pate od ludila i Alzheimerove bolesti.
YU21391A 1990-02-08 1991-02-07 Triciklični-ciklični amini kao novi inhibitori holinesteraze YU21391A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47692890A 1990-02-08 1990-02-08

Publications (1)

Publication Number Publication Date
YU21391A true YU21391A (sh) 1994-01-20

Family

ID=23893824

Family Applications (1)

Application Number Title Priority Date Filing Date
YU21391A YU21391A (sh) 1990-02-08 1991-02-07 Triciklični-ciklični amini kao novi inhibitori holinesteraze

Country Status (21)

Country Link
EP (1) EP0441517A3 (sh)
JP (1) JPH07119214B2 (sh)
KR (1) KR950013562B1 (sh)
CN (1) CN1054600A (sh)
AU (1) AU631723B2 (sh)
BR (1) BR9100519A (sh)
CA (1) CA2035805C (sh)
CS (1) CS29991A2 (sh)
DE (1) DE9101348U1 (sh)
EG (1) EG19644A (sh)
FI (1) FI910592A (sh)
HU (1) HUT70051A (sh)
IE (1) IE910402A1 (sh)
IL (1) IL97140A (sh)
NO (1) NO177534C (sh)
NZ (1) NZ237040A (sh)
PL (2) PL166757B1 (sh)
PT (1) PT96681A (sh)
TW (1) TW197442B (sh)
YU (1) YU21391A (sh)
ZA (1) ZA91916B (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
TW263504B (sh) * 1991-10-03 1995-11-21 Pfizer
TW248556B (sh) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
WO2000018391A1 (fr) 1998-09-30 2000-04-06 Takeda Chemical Industries, Ltd. Medicaments qui ameliorent le pouvoir de vidange de la vessie
CA2503767C (en) * 2002-10-30 2009-09-22 Merck Frosst Canada & Co./Merck Frosst Canada & Cie Pyridopyrrolizine and pyridoindolizine derivatives
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
WO2012038966A1 (en) 2010-09-22 2012-03-29 Tyche Industries Ltd. Process for the preparation of donepezil intermediate
TWI707859B (zh) * 2017-09-07 2020-10-21 日商衛材R&D企管股份有限公司 五環化合物
AU2020233452A1 (en) 2019-03-05 2021-09-02 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystals thereof
AR118235A1 (es) 2019-03-05 2021-09-22 Eisai R&D Man Co Ltd Heterociclos pentacíclicos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910947A (en) * 1969-07-24 1975-10-07 Sandoz Ag Preparation of imidazo{8 2,1-a{9 isoindoles
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4563469A (en) * 1984-07-20 1986-01-07 Warner-Lambert Company Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators
EP0187619A3 (de) * 1985-01-03 1987-08-26 Ciba-Geigy Ag 1,3-disubstituierte Tetrahydropyridine
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4778812A (en) * 1987-06-12 1988-10-18 American Home Products Corporation 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof
EP0351283A1 (fr) * 1988-07-12 1990-01-17 Synthelabo Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
ZA91916B (en) 1992-09-30
EG19644A (en) 1995-08-30
NO177534C (no) 1995-10-04
NO910473L (no) 1991-08-09
JPH04234845A (ja) 1992-08-24
KR910015580A (ko) 1991-09-30
NO910473D0 (no) 1991-02-07
PL288977A1 (en) 1992-01-13
PT96681A (pt) 1991-10-31
IL97140A (en) 1995-07-31
CN1054600A (zh) 1991-09-18
NO177534B (no) 1995-06-26
IE910402A1 (en) 1991-08-14
HUT70051A (en) 1995-09-28
IL97140A0 (en) 1992-05-25
AU631723B2 (en) 1992-12-03
CS29991A2 (en) 1991-09-15
FI910592A0 (fi) 1991-02-07
FI910592A (fi) 1991-08-09
PL166757B1 (pl) 1995-06-30
EP0441517A3 (en) 1992-08-19
AU7087991A (en) 1991-08-29
JPH07119214B2 (ja) 1995-12-20
NZ237040A (en) 1993-10-26
CA2035805C (en) 1995-06-27
HU910406D0 (en) 1991-08-28
KR950013562B1 (ko) 1995-11-09
EP0441517A2 (en) 1991-08-14
PL167078B1 (pl) 1995-07-31
TW197442B (sh) 1993-01-01
DE9101348U1 (sh) 1991-06-06
BR9100519A (pt) 1991-10-29

Similar Documents

Publication Publication Date Title
YU21391A (sh) Triciklični-ciklični amini kao novi inhibitori holinesteraze
FI915970A0 (fi) Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper.
MY108967A (en) Triazolopyridazine compounds, their production and use
NO810479L (no) Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater
SE8307133D0 (sv) Carboxamido-derivatives of 5h-1,3,4-thiadiazolo(3,2-a)pyrimidines and process for their preparation
MA20861A1 (fr) nouveaux derives de dihydrobenzofuranne et de chromane carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques.
ATE34575T1 (de) Neue theophyllin-derivate und verfahren zu ihrer herstellung.
FI914015A0 (fi) Menetelmä farmaseuttisesti aktiivisten 7-substituoitu-2-amino-3,5-dihydro-4H-pyrrolo/3,2-d/pyrimidin-4-onien valmistamiseksi
JPS5321188A (en) Cephalosporin analogs
FR2373546A1 (fr) Derives thio-oxime de cephalosporines et de penicillines, utiles comme inhibiteurs de b-lactamases
ES8105309A1 (es) Un procedimiento para la preparacion de nuevos derivados de cromano.
PT76335A (de) Neue basisch substituierte 4-phenyl-4,5,6,7-tetrahydro-thieno-<2,3-c>pyridine verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
IL101506A0 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
SE7902915L (sv) 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och deras anvendning sasom inhibitorer av allergiska reaktioner
ES8605256A1 (es) Un procedimiento para la preparacion de derivados de 2-feniletilamina.
NZ221054A (en) Imidazo (2,1-a) isoquinoline derivatives and pharmaceutical compositions
YU68292A (sh) 2-(2-supstituisani pirolidiniltio) karbapenem derivati
YU55495A (sh) Upotreba benzotiofena za dobijanje leka
DE3160719D1 (en) Benzothiopyrano(2,3-c) pyridines and their acid addition salts, their preparation, their use as medicaments and compositions containing them
FI821944A0 (fi) Tricykliska foereningar
NO885811L (no) Fremgangsmaate for fremstilling av 2-amino-tetrahydroisokinolinderivater.